The role of CD8+ T cells in renal cancer is controversial, maybe attribute to technical factors such as antibodies used to examine CD8+ T cells and different tumor location detected (intratumor vs invasion margins TILs) (52, 53). This evidence concerns the gene CD8A and neoplasm.